Drug Discovery Division, Korea Research Institute of Chemical Technology, P.O. Box 107, Yuseong, Daejeon 305-600, Korea.
Org Lett. 2010 Sep 17;12(18):4184-7. doi: 10.1021/ol1017905.
Asymmetric transfer hydrogenation (ATH) of cyclic sulfamidate imines 4 and 9, using a HCO(2)H/Et(3)N mixture as the hydrogen source and well-defined chiral Rh catalysts (S,S)- or (R,R)-2, Cp*RhCl(TsDPEN), effectively produces the corresponding cyclic sulfamidates with excellent yields and enantioselectivities at room temperature within 0.5 h. ATH of 4,5-disubstituted imines 9, having preexisting stereogenic centers, is shown to take place with dynamic kinetic resolution.
使用 HCO(2)H/Et(3)N 混合物作为氢源和手性 Rh 催化剂(S,S)-或(R,R)-2,Cp*RhCl(TsDPEN),对环状磺酰胺亚胺 4 和 9 进行不对称转移氢化(ATH),可在室温下于 0.5 小时内有效地以优异的收率和对映选择性得到相应的环状磺酰胺。具有预先存在的手性中心的 4,5-二取代亚胺 9 的 ATH 发生动态动力学拆分。